Merck Open Global Health Library in vitro screening against Schistosoma mansoni identified two new substances with antischistosomal activities for further development
Abstract Background Schistosomiasis, which is caused by the parasite Schistosoma mansoni as well as other species of the trematode genus Schistosoma, leads to chronic inflammation and finally to liver fibrosis. If untreated, the disease can cause life-threatening complications. The current treatment...
Saved in:
Main Authors: | Monique Evelyn Ueberall, Martina Berchthold, Cécile Häberli, Sven Lindemann, Thomas Spangenberg, Jennifer Keiser, Christoph G. Grevelding |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13071-024-06648-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spinal schistosomiasis masquerading as spinal cord tumor in a 12-year-old male adolescent: A case report
by: Gashaw Arega, et al.
Published: (2025-03-01) -
Parasitological and clinical correlates of Plasmodium–Schistosoma mansoni co-infection and its determinants among Plasmodium-infected patients in the Wolaita Zone, South Ethiopia regional state
by: Kemal Mohamed, et al.
Published: (2025-01-01) -
Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis
by: Miseganaw Sisay, et al.
Published: (2025-02-01) -
Pharmacological evidence supporting a role for IL-1, IL-2 and serotonin in the inflammation induced by Schistosoma mansoni Soluble Egg Antigen (SEA) in rat paws
by: C. M. F. Pacheco, et al.
Published: (1998-01-01) -
Intestinal schistosomiasis in remote areas of Southwest Ethiopia, a target region for large-scale mass drug administration
by: Yared Nigusu, et al.
Published: (2025-01-01)